|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Expression of adhesion molecules on CD34+ cells: CD34+ L-Selectin +cells predict a rapid platelet recovery after peripheral blood cell transplantation 显示文摘 | Dercksen MW Gerritsen WR Rodenhuis S | 1995 | Blood1995，11，： | 2 |
| 2 | System 21,Jupiter,A design system for two-dimensional nearly-horizontal flows显示文摘 | Abbott M B Damsgaard A Rodenhuis G S | 1973 | Journal of Hydraulic Research1973，11，： | 1 |
| 3 | Clinical significance of ras oncogene activation in human lung cancer 显示文摘 | Rodenhuis S Slebos R J C | 1992 | Cancer Res1992，52，9： | 1 |
| 4 | Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-Tetrahydro-4-n-propyl-2H,5H- benzopyrano-1,4-oxazin-9-ol (PD 128907)显示文摘 | VAN VLIET LA RODENHUIS N DIJKSTRA D | 2000 | JMed Chem2000，43，15： | 1 |
| 5 | The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy显示文摘 | Straver ME Rutgers EJ Rodenhuis S | | 0，，09： | 1 |
| 6 | Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer显示文摘 | Rodenhuis S Bontenbal M van Hoesel QG | 2006 | Ann Oncol2006，17，14： | 1 |
| 7 | The relevance of breast cancer subtypes i n the outcome of neoadjuvant chemotherapy显示文摘 | Straver ME Rutgers EJ Rodenhuis S | | 0，，09： | 1 |
| 8 | An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment显示文摘 | EKHART C RODENHUIS S SMITS P H | 2009 | Cancer Treat2009，35，1： | 1 |
| 9 | Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonist 显示文摘 | van Vliet LA Rodenhuis N Wikstroem H | 2000 | J Med Chem2000，43，19： | 1 |
| 10 | Further characterization of structural requirements for ligands at the dopamine D2 and D3 receptor:exploring the thiophene moiety显示文摘 | DIJKSTRA D RODENHUIS N VERMEULEN ES | 2002 | J Med Chem2002，45，14： | 1 |
| 11 | Clinical significance of ras oncogene activation in human lung cancer 显示文摘 | Rodenhuis S Slebos RJ | 1992 | Cancer Res1992，52，9： | 1 |
| 12 | Clinical significance of ras oncogene activation in human lung cancer显示文摘 | Rodenhuis S Slebos RJC | 1992 | Cancer Res1992，52，3： | 1 |
| 13 | Long-lead seasonal forecasts-Where do we stand显示文摘 | Bamston A G Dool H M Rodenhuis D R | 1994 | Bull Amer Meteorol Soc1994，75，11： | 1 |
| 14 | Immature dengue virus: a veiled pathogen? 显示文摘 | Rodenhuis - Zybert IA van der Schaar HM da Silva Voorham JM | 2010 | PLoS Pathog2010，6，10： | 1 |
| 15 | Efficacy of high-dose alkylating chemotherapy in HER2 neu-negative breast cancer显示文摘 | RODENHUIS S BONTENBAL M VAN HOESEL QGCM | 2006 | Ann Oncol2006，17，4： | 1 |
| 16 | Efficacy of high-dose alkylating Chemotherapy in HER-2/neu-negative breast cancer显示文摘 | Rodenhuis S Bontenbal M van Hoese QGCM | 2006 | Ann Oncol2006，17，14： | 1 |
| 17 | Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin,cyclophosphamide and thiotepa显示文摘 | Rodenhuis S Baars JW Schornagel JH | 1992 | Ann Oncol1992，3，： | 1 |
| 18 | System21,Jupiter,a design system for two-dimensional nearly-horizontal flows显示文摘 | Abbott M B Damsgaard A Rodenhuis G S | | 0，，： | 1 |
| 19 | An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment显示文摘 | Ekhart C Rodenhuis S Smits P H | 2009 | Cancer Treat Rev2009，35，1： | 1 |
| 20 | Mutational activation of the K-rag oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung:a prospective study显示文摘 | Rodenhuis S Boerrigter L Top B | 1997 | J Clin Oncol1997，15，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员